Baker McKenzie Baker McKenzie
How Can We Help?
Michal Berkner

Michal Berkner

Partner
Baker & McKenzie LLP

Biography

Michal is a partner in our Corporate M&A department at Baker McKenzie’s London office. She is Head of our EMEA Biopharma and Deep Tech Transactions and is both US and UK qualified.

Over the course of her career, which spans three decades, Michal has worked at a number of leading US firms, predominantly in advising clients in the life science and technology sectors.

Practice Focus

Michal is a full-service transactional lawyer with significant experience in complex, cross-border M&A, including public takeovers and mergers, private strategic transactions, bolt-ons, spin-offs, joint ventures, restructurings, financings, IPOs and regulatory matters.

Representative Legal Matters

  • Advising Baylis Medical on its USD 1.75 billion sale to Boston Scientific.
  • Advising VectivBio on its USD 1.2 billion sale to Ironwood.
  • Advising Therachon on its USD 900 million sale to Pfizer.
  • Advising Zoll on its USD 583 million acquisition of Itamar Medical.
  • Advising Bavarian Nordic on its USD 380 million acquisition of Emergent’s travel health business.
  • Advising Eagle Pharma on its USD 104 million scheme of arrangement to acquire Acacia Pharma.
  • Advising RedX Pharma on its proposed reverse merger and scheme of arrangement with Jounce Therapeutics.
  • Advising Anchiano Therapeutics on its reverse merger with Chemomab Therapeutics.
  • Advising Alvotech, Oculis and BioTE on business combinations and Nasdaq listings.
  • Advising Feedzai, Exscentia, Content Square, Cision Technologies, Clyde Space, Luna Innovations, Hipcamp and other tech companies on multiple transactions.
  • Advising Nokia Corporation on its USD 17 billion acquisition of Alcatel-Lucent, USD 1.2 billion acquisition of Motorola’s wireless network infrastructure, acquisition of Panasonic Systems Networks and joint venture with China Huaxin Telecom.
  • Advising DSV on its USD 1.3 billion acquisition of UTi Worldwide.
  • Advising Alfa-Access Renova on its USD 56 billion sale of TNK-BP to Rosneft.

Admissions

  • New York~United States
  • England & Wales~United Kingdom

Education

  • University of Pennsylvania Law School
  • Johns Hopkins University

Languages

  • English
  • French
  • Hebrew

Publications

Frequent panelist and author of 20+ articles in financial and legal publications on legal trends and developments in M&A, life sciences and technology industries.

Baker & McKenzie LLP, an English partnership, is a member of Baker & McKenzie International, a Swiss Verein.